Dijabetesni makularni edem (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dijabetesni makularni edem" in Serbian language version.

refsWebsite

Global rank Serbian rank

19doi.org

2^nd place

4^th place

18nih.gov

4^th place

8^th place

7archive.org

6^th place

5^th place

1cines.fr

low place

1web.archive.org

1^st place

archive.org

JD Walker (2009). Diabetic Retinopathy for the Comprehensive Ophthalmologist. . Chicago: Deluma Medical Publishers.
Wild S, Roglic G, Green A, Sicree R, King H (2004). „Global prevalence of diabetes: estimates for the year 2000 and projections for 2030”. Diabetes Care. 27 (5): 1047—53. PMID 15111519. doi:10.2337/diacare.27.5.1047.
King H, Aubert RE, Herman, WH (1998). „Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections”. Diabetes Care. 21 (9): 1414—31. PMID 9727886. doi:10.2337/diacare.21.9.1414.
Gaudreault, J.; Fei, D.; Rusit, J.; Suboc, P.; Shiu, V. (2005). „Preclinical pharmacokinetics of Ranibizumab (RhuFabV2) after a single intravitreal administration”. Investigative Ophthalmology & Visual Science. 46 (2): 726—733. PMID 15671306. doi:10.1167/iovs.04-0601.
Bakri, S. J.; Snyder, M. R.; Reid, J. M.; Pulido, J. S.; Ezzat, M. K.; Singh, R. J. (2007). „Pharmacokinetics of intravitreal ranibizumab (Lucentis)”. Ophthalmology. 114 (12): 2179—2182. PMID 18054637. doi:10.1016/j.ophtha.2007.09.012.
Kang, S. W.; Park, S. Y.; Ham, D. I. (2004). „The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema”. American Journal of Ophthalmology. 137 (2): 313—22. PMID 14962423. doi:10.1016/j.ajo.2003.09.016.
Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992). „Vitrectomy for diabeticmacular traction and edema associated with posterior hyaloid traction”. Ophthalmology. 99 (5): 753—9. PMID 1594222. doi:10.1016/S0161-6420(92)31901-3. .

cines.fr

imgt.cines.fr

IGMT Link:http://imgt.cines.fr/3Dstructure-DB/cgi/details.cgi?pdbcode=1CZ8&Part=Chain Архивирано на веб-сајту Wayback Machine (7. децембар 2008)

doi.org

Girach A, Lund-Andersen H (2007). „Diabetic macular edema: a clinical overview”. Int J Clin Pract. 61 (1): 88—97. PMID 17229183. doi:10.1111/j.1742-1241.2006.01211.x.
Wild S, Roglic G, Green A, Sicree R, King H (2004). „Global prevalence of diabetes: estimates for the year 2000 and projections for 2030”. Diabetes Care. 27 (5): 1047—53. PMID 15111519. doi:10.2337/diacare.27.5.1047.
King H, Aubert RE, Herman, WH (1998). „Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections”. Diabetes Care. 21 (9): 1414—31. PMID 9727886. doi:10.2337/diacare.21.9.1414.
Williams R, Airey M, Baxter H, Forrester J, Kennedy-MartinT, Girach A (2004). „Epidemiology of diabetic retinopathy and macular edema: a systemic review”. Eye. 18 (10): 963—83. PMID 15232600. doi:10.1038/sj.eye.6701476. .
Early Treatment Diabetic Retinopathy Study Report Number 4: Photocoagulation for diabetic macular edema. „Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4. The Early Treatment Diabetic Retinopathy Study Research Group”. Int Ophtalmol Clin. 27 (4): 265—272. 1987. PMID 3692708. doi:10.1097/00004397-198702740-00006.
Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—1266. PMID 18046235. doi:10.1097/IAE.0b013e318134eecd.
Gaudreault, J.; Fei, D.; Rusit, J.; Suboc, P.; Shiu, V. (2005). „Preclinical pharmacokinetics of Ranibizumab (RhuFabV2) after a single intravitreal administration”. Investigative Ophthalmology & Visual Science. 46 (2): 726—733. PMID 15671306. doi:10.1167/iovs.04-0601.
Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—1266. PMID 18046235. doi:10.1097/IAE.0b013e318134eecd.
Bakri, S. J.; Snyder, M. R.; Reid, J. M.; Pulido, J. S.; Ezzat, M. K.; Singh, R. J. (2007). „Pharmacokinetics of intravitreal ranibizumab (Lucentis)”. Ophthalmology. 114 (12): 2179—2182. PMID 18054637. doi:10.1016/j.ophtha.2007.09.012.
Kourlas, H.; Abrams, P. (2007). „Ranibizumab for the treatment of neovascular age-related macular degeneration: A review”. Clinical Therapeutics. 29 (9): 1850—1861. PMID 18035187. doi:10.1016/j.clinthera.2007.09.008.
Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. „Early Treatment Diabetic Retinopathy Study report number 1”. Archives of Ophthalmology. 103: 1796—806. 1985. doi:10.1001/archopht.1985.01050120030015. .
Kang, S. W.; Park, S. Y.; Ham, D. I. (2004). „The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema”. American Journal of Ophthalmology. 137 (2): 313—22. PMID 14962423. doi:10.1016/j.ajo.2003.09.016.
Jittpoonkunson, T.; Garcia, P.; Rosen, R. B. (2010). „Correlation between fluorescein angiography and spectral domain optical coherence tomography in the dignosis of cystoid macular edema”. Br J Ophthalmol. 94 (9): 1197—200. PMID 19965832. doi:10.1136/bjo.2009.170589.
Stefnsson, E. (2001). „The therapeutc effect of retinal laser treatment and vitrectomy”. A Theory Based on Oxygen and Vascular Physiology. Acta Ophthalmol Scand. 79 (5): 435—40. PMID 11594975. doi:10.1034/j.1600-0420.2001.790502.x.
Writing Committee for the Diabetic Retinopathy Clinical Research Network: Comparison of modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. „Comparison of the Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema”. Archives of Ophthalmology. 125 (4): 469—80. 2007. PMC 2536574 . PMID 17420366. doi:10.1001/archopht.125.4.469. .
Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992). „Vitrectomy for diabeticmacular traction and edema associated with posterior hyaloid traction”. Ophthalmology. 99 (5): 753—9. PMID 1594222. doi:10.1016/S0161-6420(92)31901-3. .
Pendergast, S. D.; Hassan TS; Williams GA; Cox MS; Margherio RR; Ferrone PJ; et al. (2000). „Vitrectomy for diffuse diabetic macular macular edema associated with a taut premacularposterior hyaloid”. American Journal of Ophthalmology. 130 (2): 178—86. PMID 11004291. doi:10.1016/S0002-9394(00)00472-4.

nih.gov

ncbi.nlm.nih.gov

Girach A, Lund-Andersen H (2007). „Diabetic macular edema: a clinical overview”. Int J Clin Pract. 61 (1): 88—97. PMID 17229183. doi:10.1111/j.1742-1241.2006.01211.x.
Wild S, Roglic G, Green A, Sicree R, King H (2004). „Global prevalence of diabetes: estimates for the year 2000 and projections for 2030”. Diabetes Care. 27 (5): 1047—53. PMID 15111519. doi:10.2337/diacare.27.5.1047.
King H, Aubert RE, Herman, WH (1998). „Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections”. Diabetes Care. 21 (9): 1414—31. PMID 9727886. doi:10.2337/diacare.21.9.1414.
Williams R, Airey M, Baxter H, Forrester J, Kennedy-MartinT, Girach A (2004). „Epidemiology of diabetic retinopathy and macular edema: a systemic review”. Eye. 18 (10): 963—83. PMID 15232600. doi:10.1038/sj.eye.6701476. .
Early Treatment Diabetic Retinopathy Study Report Number 4: Photocoagulation for diabetic macular edema. „Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4. The Early Treatment Diabetic Retinopathy Study Research Group”. Int Ophtalmol Clin. 27 (4): 265—272. 1987. PMID 3692708. doi:10.1097/00004397-198702740-00006.
Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—1266. PMID 18046235. doi:10.1097/IAE.0b013e318134eecd.
Gaudreault, J.; Fei, D.; Rusit, J.; Suboc, P.; Shiu, V. (2005). „Preclinical pharmacokinetics of Ranibizumab (RhuFabV2) after a single intravitreal administration”. Investigative Ophthalmology & Visual Science. 46 (2): 726—733. PMID 15671306. doi:10.1167/iovs.04-0601.
Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—1266. PMID 18046235. doi:10.1097/IAE.0b013e318134eecd.
Bakri, S. J.; Snyder, M. R.; Reid, J. M.; Pulido, J. S.; Ezzat, M. K.; Singh, R. J. (2007). „Pharmacokinetics of intravitreal ranibizumab (Lucentis)”. Ophthalmology. 114 (12): 2179—2182. PMID 18054637. doi:10.1016/j.ophtha.2007.09.012.
Kourlas, H.; Abrams, P. (2007). „Ranibizumab for the treatment of neovascular age-related macular degeneration: A review”. Clinical Therapeutics. 29 (9): 1850—1861. PMID 18035187. doi:10.1016/j.clinthera.2007.09.008.
Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
Kang, S. W.; Park, S. Y.; Ham, D. I. (2004). „The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema”. American Journal of Ophthalmology. 137 (2): 313—22. PMID 14962423. doi:10.1016/j.ajo.2003.09.016.
Jittpoonkunson, T.; Garcia, P.; Rosen, R. B. (2010). „Correlation between fluorescein angiography and spectral domain optical coherence tomography in the dignosis of cystoid macular edema”. Br J Ophthalmol. 94 (9): 1197—200. PMID 19965832. doi:10.1136/bjo.2009.170589.
Stefnsson, E. (2001). „The therapeutc effect of retinal laser treatment and vitrectomy”. A Theory Based on Oxygen and Vascular Physiology. Acta Ophthalmol Scand. 79 (5): 435—40. PMID 11594975. doi:10.1034/j.1600-0420.2001.790502.x.
Writing Committee for the Diabetic Retinopathy Clinical Research Network: Comparison of modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. „Comparison of the Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema”. Archives of Ophthalmology. 125 (4): 469—80. 2007. PMC 2536574 . PMID 17420366. doi:10.1001/archopht.125.4.469. .
Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992). „Vitrectomy for diabeticmacular traction and edema associated with posterior hyaloid traction”. Ophthalmology. 99 (5): 753—9. PMID 1594222. doi:10.1016/S0161-6420(92)31901-3. .
Pendergast, S. D.; Hassan TS; Williams GA; Cox MS; Margherio RR; Ferrone PJ; et al. (2000). „Vitrectomy for diffuse diabetic macular macular edema associated with a taut premacularposterior hyaloid”. American Journal of Ophthalmology. 130 (2): 178—86. PMID 11004291. doi:10.1016/S0002-9394(00)00472-4.

web.archive.org

IGMT Link:http://imgt.cines.fr/3Dstructure-DB/cgi/details.cgi?pdbcode=1CZ8&Part=Chain Архивирано на веб-сајту Wayback Machine (7. децембар 2008)